Simple Summary
The debate about the acceptance or rejection of genetically modified organisms (GMOs) has lasted for many decades. At the heart of this debate is the balance between the potential benefits of GMOs and concerns about their possible effects on human health, the environment, animal welfare and society. Over the years, several plants, animals and raw materials have been produced by GMOs for pharmaceutical, medical, industrial and agricultural purposes. Some of them became accepted and introduced into daily practice, while others were refused, especially those for human alimentation. Recently, however, since the invention of new-generation gene editing methods, there is a need to reconsider and redefine the term GMO as well as the acceptance of products created in this way.
Abstract
Genetic modification and genome editing have become important tools in agriculture, animal production, biotechnology, and human medicine, but their safety and societal acceptance remain subjects of debate. This review examines genetically modified (GM) and gene-edited organisms, distinguishing transgenesis from precision genome editing technologies, including CRISPR/Cas9, base editing, and prime editing. Representative applications in crops, livestock, pharmaceutical production, and xenotransplantation are discussed, together with their regulatory framework and public perception. Current scientific assessments indicate that approved GM foods are not inherently more hazardous to human health than their conventional counterparts when evaluated case by case. Potential benefits include improved nutritional quality, biofortification, disease resistance, increased agricultural efficiency, production of therapeutic proteins, and applications in animal health and medicine. Possible concerns include allergenicity, toxicity, unintended genetic or phenotypic effects, altered nutritional composition, environmental consequences, animal welfare issues, and uncertainties associated with long-term or large-scale deployment. Public acceptance varies substantially according to geographical region, application, cultural and ethical considerations, regulatory environment, scientific literacy, and institutional trust. Overall, GM and gene-edited organisms should not be considered a homogeneous category. Their benefits, risks, and societal acceptability depend on the specific organism, genetic modification, intended trait, and context of use, supporting a balanced, evidence-based, and case-specific approach.